Dongcheng Pharmaceutical Plans to Repurchase Up to 1.121 Billion Yuan Worth of Minority Shares in Subsidiary Lanacheng

36Kr reports that Dongcheng Pharmaceutical announced plans to repurchase 34.9232% of the shares held by minority shareholders in its subsidiary, Lanacheng, for no more than 1.121 billion yuan. Following the transaction, the company's shareholding will increase from 43.9502% to 78.8734%. The deal constitutes a related-party transaction but does not qualify as a major asset restructuring and is subject to approval by the shareholders' meeting.